Loading company…
Midatech Pharma Plc is an Abingdon-based biopharmaceutical company developing therapies for rare diseases and oncology.
Founded in 2000 and headquartered in Abingdon, UK, Midatech Pharma Plc develops eRapa, an oral formulation of rapamycin, and Tolimidone. The company completed its IPO in December 2014, raising GBP 32 million, and Stephen Stamp serves as CEO. In 2023 it reported revenue of GBP 473,939.3 and EBITDA of GBP -9,794,745.2, and its recorded stage is Series A.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in